Pulmonary Embolism Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, "Pulmonary Embolism Global Clinical Trials Review, H2, 2012" provides data on the Pulmonary Embolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Embolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Embolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Pulmonary Embolism 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Pulmonary Embolism 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Pulmonary Embolism Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Bristol-Myers Squibb Company 32
Clinical Trial Overview of Bristol-Myers Squibb Company 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
AGEN Biomedical Limited 36
Clinical Trial Overview of AGEN Biomedical Limited 36
EKOS Corporation 37
Clinical Trial Overview of EKOS Corporation 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Rovi Pharmaceuticals Laboratories 40
Clinical Trial Overview of Rovi Pharmaceuticals Laboratories 40
APEIRON Biologics AG 41
Clinical Trial Overview of APEIRON Biologics AG 41
Bracco Imaging S.p.A. 42
Clinical Trial Overview of Bracco Imaging S.p.A. 42
Daiichi Sankyo, Inc. 43
Clinical Trial Overview of Daiichi Sankyo, Inc. 43
Eisai Inc. 44
Clinical Trial Overview of Eisai Inc. 44
Agenix Limited 45
Clinical Trial Overview of Agenix Limited 45
Diagnostica Stago SAS 46
Clinical Trial Overview of Diagnostica Stago SAS 46
LEO Pharma A/S 47
Clinical Trial Overview of LEO Pharma A/S 47
Intermountain Healthcare, Inc. 48
Clinical Trial Overview of Intermountain Healthcare, Inc. 48
MCS Medical Compression Systems (DBN) Ltd. 49
Clinical Trial Overview of MCS Medical Compression Systems (DBN) Ltd. 49
Eli Lilly and Company 50
Clinical Trial Overview of Eli Lilly and Company 50
Thermo Fisher Scientific Inc. 51
Clinical Trial Overview of Thermo Fisher Scientific Inc. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Brigham and Women's Hospital 52
Clinical Trial Overview of Brigham and Women's Hospital 52
Leiden University Medical Center 53
Clinical Trial Overview of Leiden University Medical Center 53
Beijing Chao Yang Hospital 54
Clinical Trial Overview of Beijing Chao Yang Hospital 54
Ottawa Hospital Research Institute 55
Clinical Trial Overview of Ottawa Hospital Research Institute 55
University of Perugia 56
Clinical Trial Overview of University of Perugia 56
Hopitaux Universitaires de Geneve 57
Clinical Trial Overview of Hopitaux Universitaires de Geneve 57
Assistance Publique - Hopitaux de Paris 58
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 58
St. Orsola Hospital 59
Clinical Trial Overview of St. Orsola Hospital 59
University Hospital, Brest 60
Clinical Trial Overview of University Hospital, Brest 60
Carolinas Healthcare System 61
Clinical Trial Overview of Carolinas Healthcare System 61
University of Pittsburgh 62
Clinical Trial Overview of University of Pittsburgh 62
University Hospital, Grenoble 63
Clinical Trial Overview of University Hospital, Grenoble 63
McMaster University 64
Clinical Trial Overview of McMaster University 64
The Cleveland Clinic 65
Clinical Trial Overview of The Cleveland Clinic 65
St. Joseph's Healthcare Hamilton 66
Clinical Trial Overview of St. Joseph's Healthcare Hamilton 66
Ludwig-Maximilians-Universitat Munich 67
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 67
William Beaumont Hospitals 68
Clinical Trial Overview of William Beaumont Hospitals 68
Carlos III Health Institute 69
Clinical Trial Overview of Carlos III Health Institute 69
Sunnybrook Health Sciences Centre 70
Clinical Trial Overview of Sunnybrook Health Sciences Centre 70
University of Washington 71
Clinical Trial Overview of University of Washington 71
Pulmonary Embolism Global Clinical Trials Review, H2, 2012 published by GlobalData in October 18, 2012. This report consists of Pages: 221 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
